Shilpa Medicare share news and announcements
NSE: SHILPAMEDBSE: 530549Pharmaceuticals & BiotechnologySmall Cap
Last close ₹864.30up ₹3.50 (0.41%)BSE ₹862.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹860.80.
52-week range of traded prices to 23 Oct 2026
₹259.50Low, 27 Jan 2026₹1,095.00High, 1 Oct 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹16,904 Cr637th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 5 Aug 2026
- 56.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹30 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 63.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 6.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.07%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 5 Aug 2026
- 12.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹30 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 10.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 9,55,72541.8% delivered
Shilpa Medicare share news and announcements
754 announcements, routine notices left out, newest first. Page 15 of 16.
Aug 2012
10 Aug · Dividend
Board of Directors of the Company at its meeting held on August 10, 2012 has recommended a dividend of Rs.0.90 per equity share of Rs.2/- each (i.e.45%) for the Financial Year 2011-2012.3 Aug · Board meeting
To consider the following among other items: 1) To take on record the Un-Audited Results for the quarter ended June 30, 2012. 2) To take on record the Audited Financial Results for the year ended March 31, 2012. 3) To consider the payment of Dividend for the Financial year ended March 31, 2012.
May 2012
5 May · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter & year ended March 31, 2012.
Apr 2012
Mar 2012
Feb 2012
14 Feb · Management
Resignation of Mr. Abhay Bhindumadhav Upasani from the directorship of the Company due to preoccupation and the Board of the Company has considered and taken on record the same w.e.f. February 09, 2012.
Jan 2012
31 Jan · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended December 31, 2011.
Nov 2011
12 Nov · Business
Board of Directors of the Company at their meeting held on November 12, 2011 has decided to amalgamate the Raichem Life Sciences Private Limited, a Wholly Owned Subsidiary of the Company, with itself and authorized the Managing Director to take necessary steps in this respect.4 Nov · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended September 30, 2011.
Oct 2011
Sep 2011
12 Sep · Meeting
Annual General Meeting of the Company will be held on September 22, 2011.2 Sep · Corporate action
Register of Members and Share Transfer Books of the Company will be closed from September 19, 2011 to September 22, 2011 (both days inclusive) for the purpose of AGM and payment of Dividend for the year 2010-11.
Aug 2011
24 Aug · Updates
Shilpa Medicare Limited had informed the Exchange that Mr. Ajeet Singh Karan as a Nominee Director of M/s Baring India Private Equity Fund III Limited by the Board of Directors of the Company at its meeting held on January 28, 2011. The Company has now informed the Exchange that by misconception Mr. Ajeet Singh Karan has been taken as a Nominee of M/s. Baring India Private Equity Fund III Limited. In fact, Mr. Ajeet Singh Karan has been referred for considering his candidature as an Independent Director. The Board of Directors at its meeting held on August 11, 2011 has considered the same and modified the appointment of Mr. Ajeet Singh Karan as Independent Director of the Company.12 Aug · Board meeting
Board of Directors of the Company at its meeting held August 11, 2011 have subject to necessary approvals, decided to merge M/s. Raichem Life Sciences Private Limited, a 100% subsidiary of the Company, with the Company to have cost synergies and other operational benefits.11 Aug · Dividend
Board of Directors of the Company at its meeting held on August 11, 2011 has decided to recommend a dividend of @ Rs.0.80 per equity share of Rs.2/- each (i.e. 40%) for the financial year ended March 31, 2011 for consideration of shareholders at the ensuing Annual General Meeting.3 Aug · Board meeting
Inter-alia to consider and take on record the following: a) The Un-audited Financial Results for the quarter ended June 30, 2011. b) The Audited Financial Results for the year ended March 31, 2011. c) Recommendation of Dividend for the financial year 2010-2011.
Jul 2011
May 2011
3 May · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended March 31, 2011.
Feb 2011
2 Feb · Management
Mr. Ajeet Singh Karan a Nominee of Baring India Private Equity Fund III Limited has been co-opted as an Additional Director of the Company w.e.f January 28, 2011.
Jan 2011
20 Jan · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended December 31, 2010.
Oct 2010
20 Oct · Board meeting
To consider the Un-audited Financial Results of the Company for the quarter ended September 30, 2010.
Sep 2010
3 Sep · Corporate action
Shilpa Medicare Limited had informed the Exchange that the Register of Members and Share Transfer Books of the Company will be closed from September 25, 2010 to September 30, 2010 (both days inclusive) for the purpose of AGM and payment of Dividend for the year 2009-10. The Company has now informed the Exchange that the Register of Members and Share Transfer Books of the Company will be closed from September 20, 2010 to September 22, 2010 (both days inclusive) for the purpose of AGM and payment of Dividend for the year 2009-10.2 Sep · Corporate action
Register of Members and Share Transfer Books of the Company will be closed from September 25, 2010 to September 30, 2010 (both days inclusive) for the purpose of AGM and payment of Dividend for the year 2009-10.1 Sep · Dividend
Board of Directors of the Company at its meeting held on September 01, 2010 has decided to recommend a dividend of Rs.0.70 per share (i.e.35%) for the Financial Year 2009-2010.
Aug 2010
25 Aug · Board meeting
Inter alia, to transact the following (1) To take on record the Audited Annual Accounts for the year ended March 31, 2010 (2) To recommend Dividend on Equity Shares for the financial year 2009-10.16 Aug · Issue of Securities
Board of Directors decided, in accordance with provisions of the regulations of Chapter VII of the SEBI (ICDR) Regulations, 2009 and section 81(1A) of the Companies Act, 1956, and subject to the approval of shareholders, Stock Exchanges and other regulatories, to offer and issue upto 5,00,000 (Five Lakh) Equity Shares or Warrants carrying a right to subscribe to equal number of equity shares of Rs. 2/- each of the Company on preferential basis to the Promoters/Persons Acting in their Concert and to offer and issue upto 20,00,000 (Twenty Lakh) Equity Shares of Rs.2/- each on preferential basis to Baring India Private Equity Fund III Limited, at a price of Rs. 350/- or the price calculated as per the regulation 76 of Chapter VII of the SEBI (ICDR) Regulations, 2009. In this regard the Board authorized the Managing Director to issue notice to the shareholders of the Company as required under the Companies Act and the applicable Regulations of SEBI to pass necessary resolutions and take requisite approvals and do the needful.16 Aug · Sale of Shares
Mrs. Radhika Pereira wife of Mr. Carlton Pereira, Director of the Company has sold 9270 shares of Shilpa Medicare Limited on August 03, 2010 and August 04, 2010.14 Aug · Board meeting
To consider inter-alia the proposal to issue Shares/Warrants/Convertible Bonds on preferential basis.13 Aug · News Verification
News Verification : The media had reports that Shilpa Medicare Limited may sell 10% stake to a global private equity fund. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Shilpa Medicare Limited has vide its letter inter-alia stated," The company has started initial discussion with various entities on various options to mobilize fund in case of necessity and nothing has crystallized nor has reached a stage near to crystallization".
Jul 2010
20 Jul · Board meeting
To consider the Un-Audited Financial Results of the Company for the quarter ended June 30, 2010.
Apr 2010
21 Apr · Board meeting
To consider the Un-audited Financial Results of the Company for the 4th quarter and year ended March 31, 2010.